Literature DB >> 20517703

Intravascular lymphomatosis and intracerebral haemorrhage.

Maria Grazia Passarin1, Patrick Y Wen, Emanuela Vattemi, Ebba Buffone, Claudio Ghimenton, Lamberto Bontempini, Sarah Ottaviani, Anna Maria Musso, Rebecca Pedersini.   

Abstract

Intravascular lymphomatosis (IVL) is a rare, malignant B- or T-cell lymphoma with remarkable affinity for the endothelial cells of small vessels, particularly within the skin and central nervous system. It is a disease that mimics several neurological disorders, particularly those of cerebrovascular ischemic origin. The prognosis is generally poor, with a rapidly fatal outcome. As a result the diagnosis is often made at post-mortem. We report a rare case of a 73-year-old patient with IVL complicated by intracerebral haemorrhage. In literature two cases of systemic IVL complicated by intracerebral haemorrhage have been reported, but they presented initially with a disseminated intravascular coagulation (DIC). This is the first case of brain IVL complicated by intracerebral haemorrhage not associated to DIC. Increasing awareness of this disease as a differential diagnosis to a common clinical presentation may lead to more opportunities to evaluate new diagnostic and treatment approaches.

Entities:  

Mesh:

Year:  2010        PMID: 20517703     DOI: 10.1007/s10072-010-0284-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  32 in total

1.  An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome.

Authors:  T Murase; S Nakamura; K Kawauchi; H Matsuzaki; C Sakai; T Inaba; K Nasu; K Tashiro; T Suchi; H Saito
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

2.  Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis.

Authors:  M Ponzoni; G Arrigoni; V E Gould; B Del Curto; M Maggioni; A Scapinello; S Paolino; A Cassisa; C Patriarca
Journal:  Hum Pathol       Date:  2000-02       Impact factor: 3.466

3.  Change of brain MRI findings in a patient with intravascular malignant lymphomatosis.

Authors:  M Iijima; A Fujita; M Uchigata; H Katoo
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

4.  Intravascular lymphomatosis of the nervous system.

Authors:  M Szots; A Szomor; F Kover; L Pajor; S Komoly; E Kalman; E Gomori; Z Illes
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

5.  Malignant angioendotheliomatosis. Reclassification as an angiotropic lymphoma.

Authors:  C Drobacheff; D Blanc; M Zultak; P Humbert; J P Carbillet; J L Dupond; R Laurent
Journal:  Int J Dermatol       Date:  1989-09       Impact factor: 2.736

6.  Intravascular lymphomatosis presenting as an ascending cauda equina: conus medullaris syndrome: remission after biweekly CHOP therapy.

Authors:  T Nakahara; T Saito; A Muroi; Y Sugiura; M Ogata; Y Sugiyama; T Yamamoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

7.  Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations.

Authors:  R M Stroup; K Sheibani; A Moncada; L J Purdy; H Battifora
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

8.  The neurological masquerade of intravascular lymphomatosis.

Authors:  Xabier Beristain; Biagio Azzarelli
Journal:  Arch Neurol       Date:  2002-03

Review 9.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Authors:  Andrés J M Ferreri; Elías Campo; John F Seymour; Rein Willemze; Fiorella Ilariucci; Achille Ambrosetti; Emanuele Zucca; Giuseppe Rossi; Armando López-Guillermo; Miguel A Pavlovsky; Marie-Louise Geerts; Anna Candoni; Maurizio Lestani; Silvia Asioli; Mario Milani; Miguel A Piris; Stefano Pileri; Fabio Facchetti; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

10.  Intravascular lymphomatosis of the brain in a patient with myelodysplastic syndrome.

Authors:  Gregorius J Sips; Colum F Amory; Bradley N Delman; George M Kleinman; Lewis R Lipsey; Stanley Tuhrim
Journal:  Nat Rev Neurol       Date:  2009-05       Impact factor: 42.937

View more
  6 in total

1.  Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study.

Authors:  O Kastrup; J van de Nes; T Gasser; K Keyvani
Journal:  J Neurol       Date:  2011-05-10       Impact factor: 4.849

2.  Intravascular Lymphoma with an Acute Course of Cerebellar Hemorrhage: A Case Report.

Authors:  Takeo Uzuka; Fumi Higuchi; Hadzuki Matsuda; Ryohei Otani; Phyo Kim; Keisuke Ueki
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-12-15       Impact factor: 1.742

3.  Secondary Central Nerve System Lymphoma With Intratumoral Hemorrhage Suggested as Intravascular Lymphoma by Autopsy: A Case Report.

Authors:  Yutaro Suzuki; Hiroaki Tanaka; Kennichiro Suyama; Hidetoshi Mochida; Yoshio Suzuki
Journal:  J Clin Med Res       Date:  2017-10-02

4.  Intravascular Large B-Cell Lymphoma Diagnosed by Open Brain Biopsy and Achievement of Remission After Early Initiation of Chemotherapy: Case Report.

Authors:  Eisuke Tsukamoto; Takafumi Tanei; Takenori Kato; Toshinori Hasegawa
Journal:  Cureus       Date:  2022-02-07

5.  Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy.

Authors:  Sied Kebir; Klaus Kuchelmeister; Pitt Niehusmann; Michael Nelles; Young Kim; Sharmilan Thanendrarajan; Niklas Schäfer; Moritz Stuplich; Frederic Mack; Björn Scheffler; Horst Urbach; Martin Glas; Ulrich Herrlinger
Journal:  Exp Hematol Oncol       Date:  2012-12-05

6.  Intravascular Lymphoma Presenting as Myelopathy and Intracranial Hemorrhages.

Authors:  Kenta Orimo; Takuya Sasaki; Yukio Kakuta; Ichiro Imafuku
Journal:  Intern Med       Date:  2020-08-04       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.